Houston Methodist researchers identify an immunotherapy target to combat glioblastomas
HOUSTON-(April 5, 2022) – Houston Methodist researchers have identified the genetic and molecular fingerprints of different cancer and immune cells in glioblastoma, the deadliest and...
















